登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Fusion glycoprotein F0】

Fusion glycoprotein F0信息

英文名称:Respiratory syncytial virus F protein
中文名称:呼吸道合胞病毒F蛋白
靶点别称
上市药物数量:2
临床药物数量:5
最高研发阶段:批准上市

Fusion glycoprotein F0分子别名

Fusion glycoprotein F0

Fusion glycoprotein F0分子背景

The two surface glycoproteins of the mumps virus are the hemagglutinin-neuraminidase (HN) and Fusion proteins. These glycoproteins are essential for viral entry to host cells, and the spread of newly formed virions. The mumps fusion protein (F) is a 538-amino acid, class one fusion surface glycoprotein. It is responsible for the membrane fusion of virus and host cell. The un-cleaved protein has three hydrophobic regions: an amino-terminal signal peptide, an amino terminal region of F1 and the carboxyl-terminal membrane domain. This protein starts as a precursor molecule (F0), and is then cleaved into the active protein by the recognition of a R-X-L/R-R motif by a host endoprotease (furin). The F protein contains two disulfide-linked polypeptides (F1 and F2).

Fusion glycoprotein F0上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

Fusion glycoprotein F0临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定